UBS O'Connor’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.02M Sell
273,619
-62,525
-19% -$233K 0.05% 197
2025
Q1
$928K Buy
336,144
+195,844
+140% +$541K 0.03% 179
2024
Q4
$777K Buy
140,300
+92,300
+192% +$511K 0.02% 245
2024
Q3
$400K Buy
+48,000
New +$400K 0.01% 342